TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 25 filers reported holding TENAX THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,000 | -20.0% | 4,318 | 0.0% | 0.00% | – |
| Q3 2016 | $10,000 | -9.1% | 4,318 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | +37.5% | 4,318 | +13.6% | 0.00% | – |
| Q1 2016 | $8,000 | -33.3% | 3,802 | 0.0% | 0.00% | – |
| Q4 2015 | $12,000 | +9.1% | 3,802 | +7.6% | 0.00% | – |
| Q3 2015 | $11,000 | -15.4% | 3,534 | 0.0% | 0.00% | – |
| Q2 2015 | $13,000 | 0.0% | 3,534 | -12.7% | 0.00% | – |
| Q1 2015 | $13,000 | -18.8% | 4,048 | 0.0% | 0.00% | – |
| Q4 2014 | $16,000 | 0.0% | 4,048 | 0.0% | 0.00% | – |
| Q3 2014 | $16,000 | – | 4,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,108,593 | $3,326,000 | 1.32% |
| RA Capital Management | 2,670,300 | $8,011,000 | 1.15% |
| Opaleye Management Inc. | 635,000 | $1,905,000 | 0.94% |
| Broadfin Capital, LLC | 1,968,631 | $5,906,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 2,604,660 | $7,892,000 | 0.32% |
| DAFNA Capital Management LLC | 81,509 | $245,000 | 0.24% |
| ARMISTICE CAPITAL, LLC | 88,739 | $266,000 | 0.09% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $52,000 | 0.04% |
| Verition Fund Management LLC | 25,640 | $78,000 | 0.02% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 738,592 | $2,216,000 | 0.02% |